左心室辅助装置植入后右心室功能与残余二尖瓣反流决定右心衰竭发生率
该回顾性研究纳入159例术前重度二尖瓣反流并接受连续流左心室辅助装置植入的患者,基于术后右心室功能障碍、二尖瓣反流及三尖瓣反流严重程度进行两步聚类分析。结果显示术后中重度二尖瓣反流合并中重度右心室功能障碍的患者预后最差,5年生存率仅17.6%,且卒中、溶血及装置血栓发生率最高。
要点
- 术后中重度二尖瓣反流与右心室功能障碍共存预示右心衰竭。
- 该组患者5年生存率17.6%,卒中、溶血及装置血栓发生率最高。
- 术前中重度二尖瓣反流和三尖瓣反流合并中重度右心室功能障碍者可能最受益于瓣膜干预。
核心结论
- 连续流左心室辅助装置植入后,中重度二尖瓣反流和右心室功能障碍可预测右心衰竭。
- 术前中重度二尖瓣反流和三尖瓣反流合并中重度右心室功能障碍的患者可能最受益于二尖瓣和三尖瓣干预。
研究设计与样本
- 回顾性分析前瞻性收集的159例术前重度二尖瓣反流并接受连续流左心室辅助装置植入的患者数据(2003-2017年)。
- 采用对数似然距离的两步聚类分析,基于术后右心室功能障碍、二尖瓣反流严重程度和三尖瓣反流严重程度进行分组。
- 术后超声心动图参数在术后第一个月内获取。
主要发现
- 聚类分析得出3组:第1组(n=67)为轻度或更轻二尖瓣反流伴中重度右心室功能障碍;第2组(n=43)为中重度二尖瓣反流伴中重度右心室功能障碍;第3组(n=49)为中度二尖瓣反流伴轻度右心室功能障碍。
- 第2组中间质辅助循环支持评分1级占30.2%、2级占41.9%,临时机械循环支持占18.6%,三尖瓣手术占62.8%。
- 第2组卒中发生率30.2%(P = .02)、溶血39.5%(P = .01)、装置血栓30%(P = .01)最高,生存最差(46.5%;P = .01)。
- 第1、2、3组5年生存率分别为56.0%、17.6%、55.8%。
- 全人群回归分析显示术后二尖瓣反流严重程度更高与右心衰竭相关(P < .05;比值比1.6),与右心室辅助装置使用相关(P = .09;比值比1.6)。
临床怎么用
- 术后应关注二尖瓣反流严重程度与右心室功能,中重度二尖瓣反流合并中重度右心室功能障碍提示右心衰竭高风险。
- 对术前中重度二尖瓣反流和三尖瓣反流合并中重度右心室功能障碍的患者,可考虑二尖瓣和三尖瓣干预以改善预后。
局限性
- 本研究为单中心回顾性分析,样本量159例。
- 术后超声心动图参数仅在术后第一个月内获取。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The effect of significant mitral regurgitation (MR) on outcomes after continuous flow left ventricular assist device (cfLVAD) implantation remains unclear. METHODS: We performed a retrospective review of prospectively collected data from 159 patients with preoperative severe MR who underwent cfLVAD implantation (2003-2017). Two-step cluster analysis using the log-likelihood distance for post-cfLVAD implantation parameters, which included right ventricular (RV) dysfunction, MR severity, and tricuspid regurgitation (TR) severity. Post-cfLVAD implantation echocardiographic parameters were obtained within the first month. RESULTS: Cluster analysis resulted in 3 groups. Group 1 (n = 67) had mild or less MR with moderate-severe RV dysfunction (RVD). Group 2 (n = 43) had moderate-severe MR with moderate-severe RVD. Group 3 (n = 49) had moderate MR with mild RVD. Group 2 had the largest proportion with Interagency Registry for Mechanically Assisted Circulatory Support score of 1 (30.2%) and 2 (41.9%). They were more likely to undergo temporary mechanical circulatory support (18.6%) and tricuspid valve procedure (62.8%). Group 2 had the highest rate of stroke (30.2%; P = .02), hemolysis (39.5%; P = .01), device thrombosis (30%; P = .01), and worst survival (46.5%; P = .01). Survival at 5 years for groups 1, 2, and 3 were 56.0%, 17.6%, and 55.8%. Regression analysis of the entire population showed that greater MR severity after cfLVAD was associated with RV failure (P < .05; odds ratio, 1.6) and RV assist device use (P = .09; odds ratio, 1.6). After excluding tricuspid valve repairs, MR severity had a positive correlation with TR severity (R = 0.33; P < .01). CONCLUSIONS: After cfLVAD implantation, moderate-severe MR and RVD predicted RV failure. Patients with preoperative moderate-severe MR and TR coupled with moderate-severe RVD might benefit the most from mitral and tricuspid valve intervention.
引用
- Tang PC, Haft JW, Romano MA, et al. Right ventricular function and residual mitral regurgitation after left ventricular assist device implantation determines the incidence of right heart failure. J Thorac Cardiovasc Surg. 2019. PMID: 31101350. doi:10.1016/j.jtcvs.2019.03.089
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。